• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Eurofins

Eurofins’ empowerDx launches at-home blood test in U.S.

January 21, 2022 By Sean Whooley

Eurofins subsidiary empowerDx today launched its PFAS Exposure direct-to-consumer at-home test in the U.S. Luxembourg-based Eurofins touts the per- and polyfluorinated alkyl substances (PFAS) test as the first direct-to-consumer, at-home test for determining the levels of PFAS in a person’s blood and measure 47 of the PFAS “forever chemical” compounds. According to a news release, […]

Filed Under: Blood Management, Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, News Well Tagged With: Eurofins

Eurofins, Rite Aid launch OTC at-home COVID-19 test in U.S.

July 9, 2021 By Sean Whooley

Eurofins, its empowerDX subsidiary and Rite Aid announced the launch of an over-the-counter, at-home COVID-19 PCR test kit. Luxembourg-based Eurofins’ co-branded kits will be made available at all Rite Aid locations across 17 U.S. states, offering both symptomatic and asymptomatic users a way to test for COVID-19 at home, according to a news release. Eurofins […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: Eurofins, Rite Aid

Eurofins launches COVID-19 testing network to facilitate European travel

July 2, 2021 By Sean Whooley

Eurofins announced today that it opened a network of about 500 COVID-19 testing centers across Europe to help facilitate summer travel. Luxembourg-based Eurofins’ network covers major traveling hubs to provide testing accessibility in locations ranging from supermarkets to business parks and residential areas, too. According to a news release, the company’s 500-center network is already […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, Eurofins

Eurofins gains EUA for young children’s COVID test

May 21, 2021 By Sean Whooley

Eurofins announced today that it received FDA emergency use authorization (EUA) for its at-home COVID-19 testing kit for children 3 years of age and older. Luxembourg-based Eurofins’ Clinical Enterprise subsidiary became the first to receive EUA for an at-home nasal PCR test for young children with the empowerDX kit, according to a news release. In […]

Filed Under: Diagnostics, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Eurofins, FDA

Eurofins launches SARS-CoV-2 test kit

November 5, 2020 By Sean Whooley

Eurofins (Paris:ERF.PA) announced today that it launched the GSD NovaPrime SARS-CoV-2 Mplex FLA (Sanger) kit for COVID-19 testing. Luxembourg-based Eurofins’ test kit uses the fragment length analysis principle on Sanger sequencing instruments, such as the ABI 373xl, with the assay enabling each sequencer to process more than 2,000 samples per day while the kit provides sensitivity […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Eurofins

DTW: Philips’ Imaged Guided leader Landon shares global giant’s plans for minimally invasive devices

October 23, 2020 By Tom Salemi

In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse. In this conversation we’ll learn: Why Landon left Medtronic Where Philips fits into medtech’s future How Philips hopes to expand Will Philips […]

Filed Under: Device Talks Podcasts, Featured, Food & Drug Administration (FDA), Imaging, Vascular Tagged With: DxTerity Diagnostics, Eurofins, FDA, GE Healthcare, General Electric, Merit Medical Systems, Philips

FDA issues EUAs for two at-home COVID-19 tests

October 19, 2020 By Sean Whooley

Two companies announced today that they received FDA emergency use authorizations (EUAs) for at-home COVID-19 diagnostic tests. Eurofins (Paris:ERF.PA) and DxTerity Diagnostics each received the authorization for separate COVID-19 tests, one of which is nasal-based and the other saliva-based. Luxembourg-based Eurofins’ at-home nasal PCR test is touted as a minimally invasive and quick option that offers […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, DxTerity Diagnostics, Eurofins, FDA

Eurofins launches 10-minute COVID-19 exposure testing device

July 1, 2020 By Sean Whooley

Eurofins (Paris:ERF.PA) announced today that it launched its rapid point-of-care testing devices to identify past exposure to COVID-19. The serology-based, finger-prick tests detect antibodies with a sensitivity of 94.5% from 19 days following the onset of symptoms, with results coming in just 10 minutes, according to a news release. Eurofins’ CE-Marked INgezim dual-recognition immunochromatographic assays […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics Tagged With: CE Mark, coronavirus, COVID-19, Eurofins

DeviceTalks West 2019: Medtech expertise you need to know

January 9, 2020 By Chris Newmarker

There was a wide variety of expertise to be had on the show floor of DeviceTalks West, held in December 2019 in Silicon Valley. Find out about materials testing standards from Eurofins, the evolving nature of contract manufacturing at Tegra Medical, improved medical device design strategies from Triple Ring Technologies, big-box builds at Valtronic, and […]

Filed Under: Contract Manufacturing, Featured, Regulatory/Compliance Tagged With: DeviceTalks West, Eurofins, Tegra Medical, Triple Ring Technologies, Valtronic, Ximedica LLC

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS